SOSV

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Michael Aberman

Partner

Lindsay Atkenson

Analyst

Hugh Bowen

Associate

Po Bronson

General Partner

Stephen Chambers

Partner

Navin Danapal

SEA Director

Hiruy Ephrem

Analyst

Sheng Ge

Partner, Investments Operations

Weichang Ge

Analyst

TR Harrington

Partner

Bill Liao

General Partner

Ching-Ping Lin

Partner

Stephen McCann

CFO and General Partner

Carthach McCarthy

CFO

Yuan-Ting Meng

Analyst

Paul Monaghan

Principal

Eric Ramsay

Analyst

Pae Wu

General Partner

Sabriya Stukes Ph.D

Partner

Past deals in New Jersey

Cayuga Biotech

Seed Round in 2023
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.

Pons

Angel Round in 2022
PONS is a company specializing in the development of artificial intelligence to enhance ultrasound imaging, particularly for brain diagnostics. Utilizing machine learning algorithms, PONS transforms traditional ultrasound systems into smart, AI-driven diagnostic tools that improve scan resolution, tissue contrast, and noise reduction. This innovation aims to provide expert-level insights without the need for costly new hardware. The company's primary objective is to create a wearable ultrasound device to assist first responders and ambulance doctors with pre-diagnostics in challenging circumstances, facilitating early disease detection and preventive screening. By focusing on important anatomical features in ultrasound scans, PONS seeks to advance the capabilities of ultrasound technology in neurosurgery and related fields.

Cayuga Biotech

Seed Round in 2022
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.

Allozymes

Seed Round in 2021
Allozymes is a privately-held backing company that offers non-financial services.

Allozymes

Seed Round in 2021
Allozymes is a privately-held backing company that offers non-financial services.

Sophie Society

Seed Round in 2021
Sophie Society specializes in enhancing sales conversion and traffic for small to medium-sized e-commerce businesses on Amazon. The organization comprises top marketplace experts who excel in various domains, including high-level strategy, Amazon advertising, and content generation. Additionally, Sophie Society offers data discovery services aimed at analyzing strategies that contribute to the success of its clients. With a focus on global coverage, the company facilitates strategy creation, promotions, account management, and visual branding, helping businesses attract more traffic to their websites and convert leads effectively.

Cayuga Biotech

Convertible Note in 2020
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.

Cayuga Biotech

Seed Round in 2020
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.

Allozymes

Seed Round in 2020
Allozymes is a privately-held backing company that offers non-financial services.

UPCR

Seed Round in 2019
Unclaimed Property Consulting & Reporting LLC is an industry leader delivering value-added services and technology to companies facing non-compliance business risks and maintaining compliance with state unclaimed property laws. Their cost-effective compliance outsourcing solution provides you a hassle free and painless approach to unclaimed property compliance.

Paragon Pure

Seed Round in 2019
Paragon Flavors is a food company based in USA.

Portfolio.io

Seed Round in 2018
Portfolio.io allows you to create a portfolio of digital assets in under 60 seconds. No wallets. No exchanges. Zero fees.*

Diabeto

Seed Round in 2017
Diabeto, Inc. is a healthcare technology company based in Piscataway, New Jersey, focused on diabetes management solutions. Founded in 2012, the company offers a non-intrusive, Bluetooth-enabled device that wirelessly transmits glucose readings from a glucometer to a smartphone. This functionality is complemented by a smartphone application designed to analyze the data, thereby enhancing the management of diabetes for users. By leveraging mobile and web technologies, Diabeto's device facilitates the synchronization of glucometer readings, allowing users to store their information in the cloud and share it with healthcare practitioners. This approach aims to improve the health and well-being of individuals with diabetes while bridging the communication gap between patients and caregivers. As of September 2017, Diabeto operates as a subsidiary of Livongo Health, Inc.

Wine Sherpa

Seed Round in 2016
Wine Sherpa is a mobile and online platform that enhances the wine shopping experience by personalizing recommendations and simplifying the purchasing process. Each user is paired with a live wine expert who offers tailored suggestions, answers inquiries, and curates orders based on individual preferences. This personalized service aims to improve the quality of wine selections for users. The platform allows wine enthusiasts to discover various wines, read reviews, and shop from local wine shops, with options for convenient pickup or delivery. By connecting users directly with knowledgeable experts, Wine Sherpa ensures a more enjoyable and informed wine buying experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.